Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

A Psychedelic & Nutraceutical Opportunity: A Boost for the Brain and Your Portfolio

A psilocybin mushroom, also known as a magic mushroom, offers infinite medical and scientific potential…from cognitive flexibility to potentially addressing clinical depression and eating disorders. There’s a lot we still don’t kn...
Dave Jackson | September 18, 2020 |

The Revolutionary Co. That’s Breaking Through the Blood Brain Barrier

(Click image to play video) Delivery of therapeutics across the blood-brain barrier (BBB) and into the brain has been the single greatest challenge to treating hundreds of common and rare neurological diseases, including brain cancers, neurodegenerative diseases...
Dave Jackson | December 1, 2020 |

The Right Tools at the Right Time to Control Crop Disease & Boost Yields

Download the episode here . Agri-tech Company Bee Vectoring Technologies International Inc. ( TSX-V: BEE , OTCQB: BEVVF , Forum ) has pioneered a unique and natural precision agriculture system that uses commercially-grown bees to deliver biological crop ...
Stockhouse Media | July 16, 2020 |

Deep-South's Haib Copper Project to see a $2M boost

Deep South Resources (TSXV:DSM) is boosting its Haib Copper Project The company will close its first tranche this week for $300,000 The financing is expected to close mid-September Haib project 2021 drilling program results have shown the highest...
Coreena Robertson | September 5, 2023 |

Buzz on the Bullboards: Try not to get spooked by recent market performances

The TSX has moved higher despite recent volatility, which also saw a boost from earnings, which have so far been exceeding expectations, following signs of a slowdown in interest rate hikes.
Jonathon Brown | October 27, 2022 |

CVS Declares Quarterly Dividend and Gets a Boost from Relaxed Rebate Policy

CVS Healthcare announced a $0.50/share quarterly dividend yesterday and got an added boost today as news spreads regarding easing of federal restrictions on pharmacy rebate plans. CVS Health Corp. (CVS:NYSE) along with many other pharmacy benefits manag...
Streetwise Reports | July 12, 2019 |

New Carbon-in-Leach Mine to Boost Miner's Gold Production in 2019

A Haywood report reviewed this company's Q4/18 financials and the outlook for 2019. In a March 6 research note, Haywood analyst Geordie Mark reported that Endeavour Mining Corp.'s (EDV:TSX; EVR:ASX) core assets led to in-line performance in Q4/18 with the adjusted fin...
Streetwise Reports | March 11, 2019 |

Gold Gets a Boost of Rocket Fuel From Negative Bond Yields

Ladies and gentlemen, we have liftoff! After breaking out of a five-year trading range, the price of gold surged above $1,400 an ounce last week for the first time since 2013 on expectations of a U.S. rate cut. The 10-year Treasury yield fell to around 2 percent,...
Frank Holmes | June 24, 2019 |

Retrophin Shares Fall 30% on Failed Phase 3 FORT Study

Shares of Retrophin fell to a 52-week low on the news that topline results from its fosmetpantotenate Phase 3 FORT Study for PKNA treatment failed to meet expectations. Biopharmaceutical firm Retrophin Inc. (RTRX:NASDAQ) shares are trading much lower today as the co...
Streetwise Reports | August 26, 2019 |

Sanofi Pays Lexicon Pharma $260 Million to Settle Diabetes Drug Dispute

Lexicon Pharmaceuticals shares traded higher by more than 30% today after the company announced termination of its alliance with Sanofi SA and a $260 million settlement over its diabetes drug Zynquista. Yesterday afternoon, The Woodlands, Tex.-based Lexicon Pharmaceu...
Streetwise Reports | September 12, 2019 |
1 2 3 4 5 6 7 8 9 10 ...